Please visit the accessible version of this content at https://www.cdc.gov/cancer/uscs/about/data-briefs/no21-male-urologic-cancers.htm
December 2020| No. 21
U.S. Cancer Statistics: Male Urologic Cancers During 2013–2017, one of three cancers diagnosed in men was a urologic cancer. Of 302,304 urologic cancers diagnosed each year, 67% were found in the prostate, 19% in the urinary bladder, 13% in the kidney or renal pelvis, and 3% in the testis.
Incidence Male urologic cancer is any cancer that starts in men’s reproductive or urinary tract organs. The four most common sites where cancer is found are the prostate, urinary bladder, kidney or renal pelvis, and testis. Other sites include the penis, ureter, and urethra.
Figure 1. Age-Adjusted Incidence Rates for 4 Common Urologic Cancers Among Males, by Racial/Ethnic Group, United States, 2013–2017
5.0 Racial/Ethnic Group Prostate cancer is the most common 2.1 Hispanic Non-Hispanic Asian or Pacific Islander urologic cancer among men in all 6.3 Testis Non-Hispanic American Indian/Alaska Native racial/ethnic groups. 1.5 Non-Hispanic Black 7.0 Non-Hispanic White 5.7 All Males Among non-Hispanic White and Asian/Pacific Islander men, bladder 21.8 11.4 cancer is the second most common and 29.4 kidney cancer is the third most Kidney and Renal Pelvis 26.1 common, but this order is switched 23.1 22.8 among other racial/ethnic groups.
18.6 • The incidence rate for prostate 14.9 cancer is highest among non- 21.1 Urinary Bladder 19.7 Hispanic Black men. 38.7 • The incidence rates for bladder and 34.6 testicular cancer are highest among non-Hispanic White men. 84.7 54.0 • The incidence rate for kidney cancer 71.5 Prostate is highest among non-Hispanic 171.4 American Indian/Alaska Native men. 97.8 104.5
0 50 100 150 200 New cancer cases per 100,000 standard population
www.cdc.gov/uscs Please visit the accessible version of this content at https://www.cdc.gov/cancer/uscs/about/data-briefs/no21-male-urologic-cancers.htm
Age at Diagnosis Figure 2. Incidence Rates for 4 Common Male Urologic Table. Median Age at Diagnosis for 4 Common Male Cancers, by Age at Diagnosis, United States, 2013–2017 Urologic Cancers, by Racial/Ethnic Group, United States, 600 2013–2017 Cancer Site Testis Kidney and Renal Urinary 500 Kidney and Renal Pelvis Testis Pelvis Prostate Bladder Prostate All Races- 33 64 66 72 Urinary Bladder Ethnicities 400 Non-Hispanic 34 65 67 73 White 300
Non-Hispanic Black 35 61 64 69
200 Non-Hispanic American Indian/ 32 60 66 69
New cancer cases per 100,000 population Alaska Native 100 Non-Hispanic Asian or Pacific 31 63 68 72 Islander
0 <20 20-29 30-39 40-49 50-59 60-69 70-79 80+ Hispanic 29 60 66 71 Age at diagnosis (years)
Testicular cancer is more common among young men; The median age at diagnosis was different for each incidence is highest among men age 20 to 39 years and male urologic cancer and by racial/ethnic group. then decreasing. In contrast, other urologic cancers are rare among young men, and incidence increases with age (with prostate and kidney cancers peaking at age 70 to 79 years).
Data Sources More Information Data in this brief come from U.S. Cancer Statistics, the official U.S. Cancer Statistics federal cancer statistics. Prostate Cancer Bladder Cancer U.S. Cancer Statistics incidence data are from population-based Kidney Cancer registries that participate in CDC’s National Program of Cancer Registries (NPCR) and/or the National Cancer Institute’s Suggested Citation Surveillance, Epidemiology, and End Results (SEER) Program Centers for Disease Control and Prevention. United States Cancer and met high-quality data criteria for the 2019 data submission Statistics: Male Urologic Cancers. USCS data brief, no 21. Atlanta, GA: period, covering 100% of the U.S. population. Centers for Disease Control and Prevention, US Department of Health and Human Services; 2020.
Division of Cancer Prevention and Control